New Study Unveils Potential Biomarker for Multiple Sclerosis Progression and Brain Inflammation
January 2, 2026
Research, Faculty & Staff
By Julia Soudat
In a groundbreaking discovery, researchers have identified a potential biomarker that could significantly impact our understanding of multiple sclerosis (MS). Led by Professors Jen Gommerman and Valeria Ramaglia, the study sheds light on a crucial aspect of MS: the progression of the disease and its link to brain inflammation.
The research team, including the innovative work of Vanessa Gonçalves, an assistant professor in the departments of Pharmacology & Toxicology and Psychiatry, and an associate member of the Institute for Medical Science (IMS) at the Temerty Faculty of Medicine, has made a remarkable breakthrough. Gonçalves, also an independent scientist at the Centre for Addiction and Mental Health (CAMH), leads the MitoNeuroLab, where the focus is on mitochondrial dysfunction and its impact on mental health.
The lab's findings reveal how mitochondrial dysfunction plays a significant role in the aging process of mental illnesses and the onset and progression of various mental health conditions. This discovery is a significant step forward in understanding the complex relationship between mitochondria and mental health.
Another notable contribution comes from Arthur Mortha, an associate professor of immunology and the Tier 2 Canada Research Chair in mucosal immunology. Mortha's lab explores the intricate interplay between the immune system and the microorganisms that reside on the body's barrier surfaces, often without causing harm. Through pre-clinical disease models and patient samples, Mortha's research aims to unravel the role of gut microbes in protecting against or exacerbating infections and chronic inflammatory diseases.
Additionally, a recent study has made headlines with its innovative approach to treating deadly brain cancer. Researchers in Toronto successfully used focused ultrasound combined with chemotherapy, resulting in a 40% increase in survival time for patients with glioblastoma. This non-invasive technique, pioneered by Toronto scientists, has opened new doors in cancer treatment, offering hope and extended life to those affected by this devastating disease.
These groundbreaking discoveries showcase the power of scientific research and collaboration, offering new insights into various medical conditions and paving the way for improved treatments and patient outcomes.
